The Cooper Companies, Inc. (COO) Current Ratio: 1.89
Is The Cooper Companies, Inc.’s current ratio high or low?
The Cooper Companies, Inc.'s current ratio of 1.89 is 13% above its 5-year average of 1.67, near the high end of its 5-year range (1.20–2.00).
As of Sunday, June 14, 2026. 0.53% below its 12-month average of 1.90.
COO Current Ratio Chart
COO Average Current Ratio Chart
COO Current vs Average Current Ratio Chart
COO Current Ratio Metrics
CURRENT RATIO
1.89
CURRENT RATIO AVG TTM
1.90
CURRENT RATIO AVG 3Y
1.69
CURRENT RATIO AVG 5Y
1.67
CURRENT RATIO AVG 10Y
1.70
CURRENT RATIO AVG 15Y
1.87
CURRENT RATIO AVG 20Y
1.90
CURRENT VS TTM AVG
-0.53%
CURRENT VS 3Y AVG
+11.83%
CURRENT VS 5Y AVG
+13.06%
CURRENT VS 10Y AVG
+10.88%
CURRENT VS 15Y AVG
+1.27%
CURRENT VS 20Y AVG
-0.70%
COO Competitors' Current Ratio
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 1.89 | 1.90 | 1.69 | 1.67 |
| Solventum Corporation (SOLV) | $13.66B | 1.23 | 1.21 | 1.40 | 1.43 |
| Align Technology, Inc. (ALGN) | $12.52B | 1.36 | 1.29 | 1.26 | 1.29 |
| Baxter International Inc. (BAX) | $10.77B | 2.31 | 1.83 | 1.71 | 1.91 |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | 0.68 | 0.66 | 0.70 | 0.70 |
| Hologic, Inc. (HOLX) | $16.97B | 3.75 | 3.72 | 3.76 | 3.20 |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | 1.29 | 1.35 | 1.39 | 1.37 |
| Tempus AI, Inc. (TEM) | $8.35B | 3.13 | 2.71 | 2.36 | 3.23 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 5.62 | 6.05 | 5.87 | 4.96 |
| Moderna, Inc. (MRNA) | $19.80B | 3.29 | 3.48 | 3.28 | 2.72 |
Liquidity Analysis
Current Ratio
1.89
Quick Ratio
1.13
The Cooper Companies, Inc. Current Ratio Formula & Definition
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Current Ratio FAQ
- What is the current ratio for The Cooper Companies, Inc. (COO)?
- The current ratio for COO stock is 1.89.
- Is The Cooper Companies, Inc.'s current ratio high or low?
- The Cooper Companies, Inc.'s current ratio of 1.89 is 13% above its 5-year average of 1.67, near the high end of its 5-year range (1.20–2.00).
- What is the TTM average current ratio for The Cooper Companies, Inc. (COO)?
- The TTM average current ratio for COO stock is 1.90.
- What is the 3Y average current ratio for The Cooper Companies, Inc. (COO)?
- The 3Y average current ratio for COO stock is 1.69.
- What is the 5Y average current ratio for The Cooper Companies, Inc. (COO)?
- The 5Y average current ratio for COO stock is 1.67.
- What is the 10Y average current ratio for The Cooper Companies, Inc. (COO)?
- The 10Y average current ratio for COO stock is 1.70.
- What is the 15Y average current ratio for The Cooper Companies, Inc. (COO)?
- The 15Y average current ratio for COO stock is 1.87.
- What is the 20Y average current ratio for The Cooper Companies, Inc. (COO)?
- The 20Y average current ratio for COO stock is 1.90.
The Cooper Companies, Inc. Current Ratio History
| DATE | CURRENT RATIO |
|---|---|
| 2025-10-31 | 1.89 |
| 2024-10-31 | 1.91 |
| 2023-10-31 | 1.76 |
| 2022-10-31 | 1.20 |
| 2021-10-31 | 2.00 |
| 2020-10-31 | 1.27 |
| 2019-10-31 | 1.05 |
| 2018-10-31 | 2.03 |
| 2017-10-31 | 2.41 |
| 2016-10-31 | 1.74 |
| 2015-10-31 | 1.49 |
| 2014-10-31 | 1.79 |
| 2013-10-31 | 2.33 |
| 2012-10-31 | 2.51 |
| 2011-10-31 | 2.02 |
| 2010-10-31 | 2.46 |
| 2009-10-31 | 2.87 |
| 2008-10-31 | 2.06 |
| 2007-10-31 | 1.81 |
| 2006-10-31 | 1.65 |
| 2005-10-31 | 1.72 |
| 2004-10-31 | 2.61 |
| 2003-10-31 | 2.23 |
| 2002-10-31 | 1.57 |
| 2001-10-31 | 2.28 |
| 2000-10-31 | 1.73 |
| 1999-10-31 | 2.40 |
| 1998-10-31 | 2.49 |
| 1997-10-31 | 2.04 |
| 1996-10-31 | 1.28 |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White